Reports of "unsatisfactory" surgical instrument quality worry UK MHRA
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency is warning users to check that newly purchased surgical instruments, and indeed all other devices, are fit for purpose after receiving a number of complaints that the quality of some surgical instruments is unsatisfactory1. The agency urges purchasers to be cautious when devices are offered for purchase below the current market rate as this may indicate "counterfeit or products of substandard quality assurance".
You may also be interested in...
The European public assessment report for Novartis's advanced breast cancer therapy, Piqray (alpelisib), includes some interesting insights into what EU regulators are looking for in drug company clinical trials.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.
The loss of fast-track status for setmelanotide at the European Medicines Agency means the review of the potential treatment of two rare genetic disorders of obesity will take longer than Rhythm Pharmaceuticals had originally hoped.